부산대학교 도서관

Gorovits B; Regeneron Pharmaceuticals, Inc, Tarrytown, USA. boris.gorovits@regeneron.com.; Azadeh M; Progeria Research Foundation, Inc., Cambridge, Massachusetts, USA.; Fiscella M; REGENXBIO Inc, Rockville, USA.; Harrison T; Precision for Medicine Inc., Frederick, Maryland, USA.; Hofer M; Jefferson Institute for Bioprocessing, Lower Gwynedd, USA.; Janetzki S; ZellNet Consulting, Inc, Fort Lee, New Jersey, USA.; Jawa V; EpiVax, Inc, Providence, Rhode Island, USA.; Long B; 4D Molecular Therapeutics, Emeryville, USA.; Lu Y; Sangamo Therapeutics, Inc, Richmond, USA.; Mahnke YD; FlowKnowHow LLC, New York, USA.; Maia M; South San Francisco, CA, USA.; Majumdar R; LabCorp Holdings, Inc, Burlington, USA.; Miller M; Miller Bioanalytical Consulting LLC, Carlsbad, USA.; Milton M; Lake Boon Pharmaceutical Consulting, LLC, Hudson, USA.; Nelson R; BioAgilytix Labs, LLC, Durham, USA.; Partridge MA; Regeneron Pharmaceuticals, Inc, Tarrytown, USA.; Shaik S; Takeda Pharmaceutical Company Limited, Cambridge, USA.; Snoeck V; UCB, B-1420, Braine-l'Alleud, Belgium.; Vettermann C; 4D Molecular Therapeutics, Emeryville, USA.; Wu B; Johnson & Johnson Innovative Medicine, Titusville, USA.; Zhao A; Regeneron Pharmaceuticals, Inc, Tarrytown, USA.

Publisher: American Association of Pharmaceutical Scientists Country of Publication: United States NLM ID: 101223209 Publication Model: Electronic Cited Medium: Internet ISSN: 1550-7416 (Electronic) Linking ISSN: 15507416 NLM ISO Abbreviation: AAPS J Subsets: MEDLINE

Grudzinska-Goebel J; Preclinical Development, Pharmaceuticals R&D, Bayer AG, Berlin, Germany.; Benstein K; Translational Medicine Unit, Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany.; Bloem K; R&D Antibodies and Immunogenicity, Pharma and Biotech Services, Sanquin Diagnostic Services, Amsterdam, Netherlands.; Cowan KJ; Drug Metabolism and Pharmacokinetics, New Biological Entities, Research and Development, Merck KGaA, Darmstadt, Germany.; Gorovits B; Bioanalytical Sciences, Regeneron Pharmaceuticals Inc., Tarrytown, NY, United States.; Jadhav M; Pharmacokinetic Sciences - Drug Disposition, Biomedical Research, Novartis, Cambridge, MA, United States.; Janssen M; SciPot Consultancy B.V, Amsterdam, Netherlands.; Jawa V; Translational Medicine, Bristol Myers Squibb, Lawrenceville, NJ, United States.; Kiessling A; Precliclinical Safety, Biomedical Research, Novartis, Basel, Switzerland.; Kramer D; Translational Medicine Unit, Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany.; Kromminga A; Biolytics, BioNTech SE, Mainz, Germany.; Kromminga Consulting, Hamburg, Germany.; van der Linden M; Bioanalytical Science, Genmab B.V., Utrecht, Netherlands.; Liu S; Translational Clinical Sciences, Biologics & Immunogenicity, Clinical Bioanalytics, Pfizer, Vaughan, ON, Canada.; Lotz GP; Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Munich, Penzberg, Germany.; Luo L; Regulated Bioanalytics, Merck & Co., Inc., Rahway, NJ, United States.; Malisauskas M; Non-Clinical Safety Research, H. Lundbeck A/S, Valby, Denmark.; Marban-Doran C; Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, Basel, Switzerland.; Mytych DT; Clinical Immunology Department, Clinical Development, Amgen, Inc., Thousand Oaks, CA, United States.; Oquendo Cifuentes E; Drug Metabolism and Pharmacokinetics, Boehringer-Ingelheim Pharmaceuticals Inc, Ridgefield, CT, United States.; Pippig S; Scientific Affairs, Formycon, Martinsried, Germany.; Ribes S; Global Clinical Development, Hexal AG (a Sandoz company), Holzkirchen, Germany.; Rouwette M; Bioanalysis & Protein Interaction Department, Byondis B.V., Nijmegen, Netherlands.; Shao W; Integrated Bioanalysis, Clinical Pharmacology and Safety Sciences, AstraZeneca, Gaithersburg, MD, United States.; Tourdot S; Pharmacokinetics, Dynamics and Metabolism, Pfizer Inc., Andover, MA, United States.; Weldingh KN; Non-Clinical and Clinical Assay Sciences, Novo Nordisk A/S, Måløv, Denmark.; Snoeck V; Precision Medicine, Early Clinical Development & Translational Science, UCB, Braine-l'Alleud, Belgium.

Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Tounekti O; Health Canada, Ottawa, Ontario, Canada.; Shubow S; US FDA, Silver Spring, Maryland, United States.; Wassmer S; Health Canada, Ottawa, Ontario, Canada.; Van Tuyl A; AstraZeneca, Gaithersburg, Maryland, United States.; Yang L; BioMarin, Novato, California, United States.; Gong B; US FDA, Jefferson, Arkansas, United States.; Abhari MR; Novartis, Cambridge, Massachusetts, United States.; Kalina W; Pfizer, Pearl River, New York, United States.; Myler H; Takeda, Yardley, Pennsylvania, United States.; DelCarpini J; Moderna, Cambridge, Massachusetts, United States.; Escobar D; Navigate, Carlsbad, California, United States.; Fiscella M; REGENXBIO, Rockville, Maryland, United States.; Gorovits B; Regeneron, Tarrytown, New York, United States.; Gupta S; AbbVie, Irvine, California, United States.; Irvin SC; Regeneron, Tarrytown, New York, United States.; Irwin C; Health Canada, Ottawa, Ontario, Canada.; Jankowski W; US FDA, Silver Spring, Maryland, United States.; Jawa V; Bristol Myers Squibb, Lawrenceville, New Jersey, United States.; Karauzum H; Pfizer, Pearl River, New York, United States.; Kerridge C; UK MHRA, London, United Kingdom.; Lu Y; Sangamo, Richmond, California, United States.; Mayer C; Austria AGES/ EU EMA, Vienna, Austria.; McGregor J; WRIB, Toronto, Ontario, Canada.; Melton A; AstraZeneca, Gaithersburg, Maryland, United States.; Murphy R; Sanofi, Swiftwater, Pennsylvania, United States.; Nanra J; GSK, Cambridge, Massachusetts, United States.; Nowocin A; UK MHRA, London, United Kingdom.; Partridge MA; Regeneron, Tarrytown, New York, United States.; Prior S; UK MHRA, London, United Kingdom.; Sauna Z; US FDA, Silver Spring, Maryland, United States.; Scott B; Health Canada, Ottawa, Ontario, Canada.; Seitzer J; Intellia, Windham, New Hampshire, United States.; Stern M; Bristol Myers Squibb, Lawrenceville, New Jersey, United States.; Sugimoto H; Takeda, Cambridge, Massachusetts, United States.; Taylor M; Moderna, Cambridge, Massachusetts, United States.; Wong A; Health Canada, Ottawa, Ontario, Canada.; Xiao W; US FDA, Silver Spring, Maryland, United States.; Xu Y; Intellia, Cambridge, Massachusetts, United States.; Yang TY; J&J Innovative Medicine, Spring House, Pennsylvania, United States.; Yuill D; AstraZeneca, Cambridge, United Kingdom.; Kubiak RJ; Third Arc Bio, Lower Gwynedd, Pennsylvania, United States.; Thway T; Eisai, Nutley, New Jersey, United States.; Gunn G; GSK, Collegeville, Pennsylvania, United States.; Pelto R; Alexion, Higganum, Connecticut, United States.; Sumner G; Regeneron, Tarrytown, New York, United States.; Baltrukonis D; Pfizer, Groton, Connecticut, United States.; Dholakiya SL; Bristol Myers Squibb, Lawrenceville, New Jersey, United States.; Dogmanits S; GSK, Collegeville, Pennsylvania, United States.; Garofolo F; BRI Frontage, Vancouver, British Columbia, Canada.; Jadhav M; Novartis, Cambridge, Massachusetts, United States.; Kramer D; Sanofi, Frankfurt am Main, Germany.; Meyer E; GSK, Collegeville, Pennsylvania, United States.; Mohapatra S; Stoke, Bedford, Massachusetts, United States.; Mozaffari R; GSK, Collegeville, Pennsylvania, United States.; Peng K; Genentech, South San Francisco, California, United States.; Pine S; Sanofi, Zwijnaarde, Belgium.; Poetzl J; Sandoz, Holzkirchen, Germany.; Rasamoelisolo M; Teva, West Chester, Pennsylvania, United States.; Shao W; BioMarin, Novato, California, United States.; Staack RF; Roche Pharma Research & Early Development, Roche Innovation Center, Munich, Germany.; Swanson S; Genentech, South San Francisco, California, United States.; Taqui A; Gilead, Foster City, California, United States.; Vauleon S; F. Hoffmann-La Roche, Basel, Switzerland.; Wang Y; Lilly, Indianapolis, Indiana, United States.; Wen Y; Lilly, Indianapolis, Indiana, United States.

Publisher: Taylor & Francis Country of Publication: England NLM ID: 101512484 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1757-6199 (Electronic) Linking ISSN: 17576180 NLM ISO Abbreviation: Bioanalysis Subsets: MEDLINE

Toikka, A. M.; Gorovits, B. I.; Toikka, M. A.

Russian Journal of Physical Chemistry A: Focus on Chemistry. 96(3):478-484

Donley J; Pfizer Biomedicine Design, Andover, Massachusetts, USA.; Jani D; Pfizer Inc, Cambridge, Massachusetts, USA.; Zhu T; Pfizer Inc, Cambridge, Massachusetts, USA.; Xiang Y; Pfizer Biomedicine Design, Andover, Massachusetts, USA.; Gorovits B; Pfizer Biomedicine Design, Andover, Massachusetts, USA.; Arkin S; Rare Disease Research Unit, Pfizer Worldwide Research & Development, 610 Main St., 2nd Floor, Cambridge, Massachusetts, 02139, USA. steven.arkin@pfizer.com.

Publisher: American Association of Pharmaceutical Scientists Country of Publication: United States NLM ID: 101223209 Publication Model: Electronic Cited Medium: Internet ISSN: 1550-7416 (Electronic) Linking ISSN: 15507416 NLM ISO Abbreviation: AAPS J Subsets: MEDLINE

Gorovits, B.; Baltrukonis, D. J.; Bhattacharya, I.; Birchler, M. A.; Finco, D.; Sikkema, D.; Vincent, M. S.; Lula, S.; Marshall, L.; Hickling, T. P.

Clin Exp Immunol

Gorovits, B.; Hays, A.; Jani, D.; Jones, C.; King, C.; Lundequist, A.; Mora, J.; Partridge, M.; Pathania, D.; Ramaswamy, S. S.; Rutwij, D.; Shen, H.; Starling, G.

The AAPS Journal: An Official Journal of the American Association of Pharmaceutical Scientists. 23(2)

Reagan, Lawrence P.; Gorovits, Naira; Hoskin, Elena K.; Alves, Stephen E.; Katz, Ellen B.; Grillo, Claudia A.; Piroli, Gerardo G.; McEwen, Bruce S.; Charron, Maureen J.

Proceedings of the National Academy of Sciences of the United States of America, 2001 Feb . 98(5), 2820-2825.

Gorovits B; Pfizer Inc., 1 Burtt Rd., Andover MA 01810, USA.

Publisher: Taylor & Francis Country of Publication: England NLM ID: 101512484 Publication Model: Print Cited Medium: Internet ISSN: 1757-6199 (Electronic) Linking ISSN: 17576180 NLM ISO Abbreviation: Bioanalysis Subsets: MEDLINE

DiJoseph JF; Department of Oncology Discovery, Wyeth Research, Pearl River, NY 10965, USA.; Armellino DC; Boghaert ER; Khandke K; Dougher MM; Sridharan L; Kunz A; Hamann PR; Gorovits B; Udata C; Moran JK; Popplewell AG; Stephens S; Frost P; Damle NK

Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0006-4971 (Print) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

Tounekti O; Health Canada, Ottawa, ON, Canada.; Prior S; UK MHRA, London, UK.; Wassmer S; Health Canada, Ottawa, ON, Canada.; Xu J; US FDA, Jefferson, AR, USA.; Wong A; Health Canada, Ottawa, ON, Canada.; Fang X; AskBio, Research Triangle Park, NC, USA.; Sonderegger I; Takeda, Opfikon, Switzerland.; Smeraglia J; AstraZeneca, Cambridge, UK.; Huleatt J; Gates Medical Research Institute, Cambridge, MA, USA.; Loo L; Vertex, Boston, MA, USA.; Beaver C; Takeda, Cambridge, MA, USA.; DelCarpini J; Moderna, Mystic, CT, USA.; Dessy F; GlaxoSmithKline, Rixensart, Belgium.; Diebold S; UK MHRA, London, UK.; Fiscella M; REGENXBIO, Rockville, MD, USA.; Garofolo F; BRI Frontage, Vancouver, BC, Canada.; Grimaldi C; Regeneron, Tarrytown, NY, USA.; Gupta S; AbbVie, Irvine, CA, USA.; Hou V; Moderna, Mystic, CT, USA.; Irwin C; Health Canada, Ottawa, ON, Canada.; Jani D; Takeda, San Diego, CA, USA.; Joseph J; Health Canada, Ottawa, ON, Canada.; Kalina W; Pfizer, Pearl River, NY, USA.; Kar S; WRIB, Toronto, ON, Canada.; Kavita U; Spark, Philadelphia, Pa, USA.; Lu Y; Sangamo, South San Francisco, CA, USA.; Marshall JC; Moderna, Mystic, CT, USA.; Mayer C; Austria AGES, Vienna, Austria.; Mora J; Bristol Myers Squibb, Lawrenceville, NJ, USA.; Nolan K; Merck, West Point, PA, USA.; Peng K; Genentech, South San Francisco, CA, USA.; Riccitelli N; Navigate, a Novartis Subsidiary, San Diego, CA, USA.; Scully I; Pfizer, Pearl River, NY, USA.; Seitzer J; Intellia, Cambridge, MA, USA.; Stern M; Bristol Myers Squibb, Lawrenceville, NJ, USA.; Wadhwa M; UK MHRA, London, UK.; Xu Y; Intellia, Cambridge, MA, USA.; Verthelyi D; US FDA, Silver Spring, MD, USA.; Sumner G; Regeneron, Tarrytown, NY, USA.; Clements-Egan A; Larimar, Bala Cynwyd, PA, USA.; Chen C; AstraZeneca, South San Francisco, CA, USA.; Gorovits B; Regeneron, Tarrytown, NY, USA.; Torri A; Regeneron, Tarrytown, NY, USA.; Baltrukonis D; Pfizer, Groton, CT, USA.; Gunn G; GlaxoSmithKline, Collegeville, PA, USA.; Ishii-Watabe A; Japan MHLW, Tokyo, Japan.; Kramer D; Sanofi, Frankfurt, Germany.; Kubiak RJ; AstraZeneca, Gaithersburg, MD, USA.; Mullins G; Eli Lilly and Company, Indianapolis, IN, USA.; Pan L; Takeda, Cambridge, MA, USA.; Partridge MA; Regeneron, Tarrytown, NY, USA.; Poetzl J; Sandoz, Oberhaching, Germany.; Rasamoelisolo M; Teva, West Chester, PA, USA.; Sirtori FR; EMD Serono, Ivrea, TO, Italy.; Richards S; Sanofi, Cambridge, MA, USA.; Saad OM; Genentech, South San Francisco, CA, USA.; Shao W; AstraZeneca, Gaithersburg, MD, USA.; Song Y; Genentech, South San Francisco, CA, USA.; Song S; Takeda, Cambridge, MA, USA.; Staack RF; Roche Pharma Research & Early Development, Roche Innovation Center, Munich, Germany.; Wu B; Johnson & Johnson Innovative Medicine, Spring House, PA, USA.; Manangeeswaran M; US FDA, Silver Spring, MD, USA.; Thacker S; US FDA, Silver Spring, MD, USA.

Publisher: Taylor & Francis Country of Publication: England NLM ID: 101512484 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1757-6199 (Electronic) Linking ISSN: 17576180 NLM ISO Abbreviation: Bioanalysis Subsets: MEDLINE

Gorovits B; Sana Biotechnology, Cambridge, Massachusetts, USA. boris.gorovits@sana.com.; Azadeh M; Ultragenyx Pharmaceutical Inc, Novato, California, USA.; Buchlis G; University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Fiscella M; Regenxbio Inc, Rockville, Maryland, USA.; Harrison T; Precision for Medicine, Inc, Redwood City, California, USA.; Havert M; Gene Therapy Partners, San Diego, California, USA.; Janetzki S; ZellNet Consulting, Inc, Fort Lee, New Jersey, USA.; Jawa V; Bristol Myers Squibb Pharmaceutical, Princeton, New Jersey, USA.; Long B; BioMarin Pharmaceutical Inc, Novato, California, USA.; Mahnke YD; FlowKnowHow LLC, Brooklyn, New York, USA.; McDermott A; Labcorp Early Development Laboratories Inc, Indianapolis, Indiana, USA.; Milton M; Lake Boon Pharmaceutical Consulting LLC, Hudson, New York, USA.; Nelson R; BioAgilytix Europe GmbH, Hamburg, Germany.; Vettermann C; BioMarin Pharmaceutical Inc, Novato, California, USA.; Wu B; Janssen Pharmaceuticals, Raritan, New Jersey, USA.

Publisher: American Association of Pharmaceutical Scientists Country of Publication: United States NLM ID: 101223209 Publication Model: Electronic Cited Medium: Internet ISSN: 1550-7416 (Electronic) Linking ISSN: 15507416 NLM ISO Abbreviation: AAPS J Subsets: MEDLINE

Wang Y; BioMedicine Design, Pfizer, Andover, MA, United States of America. Electronic address: ying.wang9@pfizer.com.; Luong M; BioMedicine Design, Pfizer, Andover, MA, United States of America.; Guadiz C; BioMedicine Design, Pfizer, Andover, MA, United States of America.; Zhang M; BioMedicine Design, Pfizer, Andover, MA, United States of America.; Gorovits B; BioMedicine Design, Pfizer, Andover, MA, United States of America.

Publisher: Elsevier Country of Publication: Netherlands NLM ID: 1305440 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7905 (Electronic) Linking ISSN: 00221759 NLM ISO Abbreviation: J Immunol Methods Subsets: MEDLINE

Gorovits B; Pfizer Inc., Andover, MA, USA. Boris.Gorovits@pfizer.com.; Fiscella M; REGENXBIO Inc., Rockville, MD, USA.; Havert M; bluebird bio, Cambridge, MA, USA.; Koren E; Precision for Medicine, Inc., Costa Mesa, CA, USA.; Long B; BioMarin Pharmaceutical Inc, Novato, CA, USA.; Milton M; Novartis Institutes for BioMedical Research, Inc., Cambridge, MA, USA.; Purushothama S; Alzheimer's Drug Discovery Foundation, New York, NY, USA.

Publisher: American Association of Pharmaceutical Scientists Country of Publication: United States NLM ID: 101223209 Publication Model: Electronic Cited Medium: Internet ISSN: 1550-7416 (Electronic) Linking ISSN: 15507416 NLM ISO Abbreviation: AAPS J Subsets: PubMed not MEDLINE; MEDLINE

Gorovits B; Sana Biotechnology, Inc., Cambridge, Massachusetts, USA. boris.gorovits@sana.com.; Azadeh M; Alkermes, Waltham, Massachusetts, USA.; Buchlis G; University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Harrison T; Precision for Medicine, Bethesda, Maryland, USA.; Havert M; bluebird bio, Cambridge, Massachusetts, USA.; Jawa V; Bristol Myers Squibb, Princeton, New Jersey, USA.; Long B; BioMarin Pharmaceutical Inc., Novato, California, USA.; McNally J; BioAgilytix, Durham, North Carolina, USA.; Milton M; Novartis, Cambridge, Massachusetts, USA.; Nelson R; Covance by Labcorp, Geneva, Switzerland.; O'Dell M; Covance by Labcorp, Indianapolis, Indiana, USA.; Richards K; Precision for Medicine, Bethesda, Maryland, USA.; Vettermann C; BioMarin Pharmaceutical Inc., Novato, California, USA.; Wu B; Johnson & Johnson, Spring House, Pennsylvania, USA.

Publisher: American Association of Pharmaceutical Scientists Country of Publication: United States NLM ID: 101223209 Publication Model: Electronic Cited Medium: Internet ISSN: 1550-7416 (Electronic) Linking ISSN: 15507416 NLM ISO Abbreviation: AAPS J Subsets: MEDLINE

Joyce A; Pfizer, Inc., Worldwide Research & Development, Biomedicine Design, 1 Burtt Road, Andover, Massachusetts, USA. Alison.Joyce@pfizer.com.; Shea C; Pfizer, Inc., Worldwide Research & Development, Biomedicine Design, 1 Burtt Road, Andover, Massachusetts, USA.; You Z; Pfizer, Inc, Worldwide Research & Development, Early Clinical Development, 1 Burtt Road, Andover, Massachusetts, USA.; Gorovits B; Pfizer, Inc., Worldwide Research & Development, Biomedicine Design, 1 Burtt Road, Andover, Massachusetts, USA.; Development Sciences, Sana Biotechnology, Inc., 300 Technology Square, Cambridge, Massachusetts, USA.; Lepsy C; Pfizer, Inc., Worldwide Research & Development, Biomedicine Design, 1 Burtt Road, Andover, Massachusetts, USA.

Publisher: American Association of Pharmaceutical Scientists Country of Publication: United States NLM ID: 101223209 Publication Model: Electronic Cited Medium: Internet ISSN: 1550-7416 (Electronic) Linking ISSN: 15507416 NLM ISO Abbreviation: AAPS J Subsets: MEDLINE

Sailstad, J. M.; Amaravadi, L.; Clements-Egan, A.; Gorovits, B.; Myler, H. A.; Pillutla, R. C.; Pursuhothama, S.; Putman, M.; Rose, M. K.; Sonehara, K.; Tang, L.; Wustner, J. T.

The AAPS Journal: An Official Journal of the American Association of Pharmaceutical Scientists. May 2014 16(3):488-498

Braun M; Bayer AG, Pharmaceuticals R&D, 13342 Berlin, Germany.; Lange C; Bayer AG, Pharmaceuticals R&D, 13342 Berlin, Germany.; Schatz P; Bayer AG, Pharmaceuticals R&D, 13342 Berlin, Germany.; Long B; BioMarin Pharmaceutical Inc, Novato, CA, USA.; Stanta J; Celerion Switzerland AG, 8320 Fehraltorf, Switzerland.; Gorovits B; Sana Biotechnology, 100 Technology Square, Cambridge, MA 02139, USA.; Tarcsa E; Abbvie Bioresearch Center, Worcester, MA 01605, USA.; Jawa V; Bristol Myers Squibb, Lawrence Township, NJ 08648, USA.; Yang TY; Janssen R&D LLC, Spring House, PA 19477, USA.; Lembke W; Integrated Biologix GmbH, 4051 Basel, Switzerland.; Miller N; Ultragenyx Pharmaceutical Inc, Novato, CA 94949, USA.; McBlane F; Novartis, Basel, Switzerland.; Christodoulou L; UCB Pharma, 216 Bath Road, SL1 4EN Slough, UK.; Yuill D; AstraZeneca, 1 Francis Crick Avenue, CB2 0AA Cambridge, UK.; Milton M; Lake Boon Pharmaceutical Consulting, LLC, Hudson, MA 01749, USA.

Publisher: Cell Press Country of Publication: United States NLM ID: 101624857 Publication Model: eCollection Cited Medium: Print ISSN: 2329-0501 (Print) Linking ISSN: 23290501 NLM ISO Abbreviation: Mol Ther Methods Clin Dev Subsets: PubMed not MEDLINE

Lotz GP; Roche Pharma Research and Early Development, Roche Innovation Center Munich, Penzberg, Germany. gregor.lotz@roche.com.; Benstein K; Sanofi-Aventis Deutschland GmbH, Industriepark Hoechst, Frankfurt am Main, Germany.; Bloem K; Biologics Lab, Sanquin Diagnostic Services, Amsterdam, The Netherlands.; Buddiger H; Genmab B.V., Uppsalalaan 15, Utrecht, The Netherlands.; Calonder C; Novartis Institutes for BioMedical Research, Basel, Switzerland.; Elm S; Amgen Research (Munich) GmbH, Munich, Germany.; Fernandez E; Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland.; Goodman J; Integrated Bioanalysis, Clinical Pharmacology and Safety Sciences, AstraZeneca, BioPharmaceuticals R&D, Cambridge, UK.; Gorovits B; Sana Biotechnology, Inc., MA, Cambridge, USA.; Grudzinska-Goebel J; Bayer AG, Drug Metabolism & Pharmacokinetics, Berlin, Germany.; Janssen M; SciPot Consultancy, Amsterdam, The Netherlands.; Jawa V; Bristol Myers Squibb, Biotherapeutics and Bioanalysis Non-Clinical Development, Princeton, New Jersey, USA.; Kramer D; Sanofi-Aventis Deutschland GmbH, Industriepark Hoechst, Frankfurt am Main, Germany.; Luo L; Regulated BA, Merck & Co., Inc., Kenilworth, New Jersey, USA.; Malisauskas M; Merck KGaA, Darmstadt, Germany.; Michaut L; Integrated Biologix, Basel, Switzerland.; Schäfer M; Roche Pharma Research and Early Development, Roche Innovation Center Munich, Penzberg, Germany.; Spindeldreher S; Integrated Biologix, Basel, Switzerland.; Ullmann M; Fresenius Kabi, Eysins, Switzerland.; Nana Weldingh K; Novo Nordisk, Non-clinical & Clinical Assay Sciences, Maaloev, Denmark.; Kromminga A; Kromminga Consulting, Hamburg, Germany.; Institute for Immunology, Kiel, Germany.; Snoeck V; UCB Biopharma SRL, Translational Biomarkers and Bioanalysis, Braine-l'Alleud, Belgium.

Publisher: American Association of Pharmaceutical Scientists Country of Publication: United States NLM ID: 101223209 Publication Model: Electronic Cited Medium: Internet ISSN: 1550-7416 (Electronic) Linking ISSN: 15507416 NLM ISO Abbreviation: AAPS J Subsets: MEDLINE

Toikka, M. A.; Gorovits, B. I.; Toikka, A. M.

Russian Journal of Applied Chemistry. February 2008 81(2):223-230